Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

Recent News and Articles on the Keywords: hepatitis + same + block  Related to the article below (Last Update: 8/5/2008)

Beacon Hill Roll Call: Legislature lowers gun fees, but says no to ... Wicked Local Roslindale, MA - State officials have used this law, upheld in 2004 by the Supreme Judicial Court, to prevent out-of-state same-sex couples from marrying here. ... The Olympics marks China's long-awaited coming-out party, writes ... Irish Times, Ireland - Aug 2, 2008 A mild-mannered, slight figure who suffers from hepatitis B, 34-year-old Hu was detained by police in late December after spending more than 200 days under ... Sick and Down RedOrbit, TX - Jul 27, 2008 While Miller knows that hepatitis C patients often benefit from the new generation of immuneboosting treatments, he's keenly aware that those same immune ... Hawk doctor a champion healer Real Footy, Australia - Jul 25, 2008 The things he saw, tetanus and malaria, hepatitis and ever-present heat, have been in his thoughts once again. It's been an exhausting year but one that ... Nucleonics Co-Founders Deny Misconduct Claims, Downplay CEO?s Role ... RNAi News (subscription), NY - Jul 31, 2008 In June, RNAi News reported that Nucleonics had put itself on the block after failing to close the Series C financing (see RNAi News, 6/18/2008). ... Daily Mail Marco Pierre White, his brother, and a simmering feud Daily Mail, UK - Jul 30, 2008 It was prompted by news, filtered through to him via other relatives, that his uncle Gianfranco was seriously ill with hepatitis C. Simons says: 'Out of the ... Goal.com Bar?a Confident Over Messi Stay Goal.com, Switzerland - Jul 20, 2008 However, time is not on Barcelona's side, as Messi was vaccinated against hepatitis B and other diseases earlier this week in order to be able to fly to ... Banned, Censored, Harassed and Jailed Media For Freedom, Nepal - Jul 23, 2008 In 2004, he was operated on for gallstones and reportedly suffers from multiple health problems, including digestive problems, hypertension and hepatitis. ... Full Transcript of Vital VOICE ***EXCLUSIVE*** interview with ... Vital VOICE, MO - Jul 11, 2008 LH: Obviously you can?t disclose any conversations you had with Paul McKee but did he give you any guarantees that he?s not block busting or did he give you ... When Kids Go To Prison, plus 100 Rockin' Lawsuits San Diego Reader, CA - Jul 30, 2008 In her case, with HIV, TB, and three kinds of hepatitis running rampant in California prisons, it pays to be picky. After a few weeks' processing, ...

Hepatitis A and Hepatitis C Attack Same Protein to Block Immune Defenses

GALVESTON, Texas -- Despite the fact that they both infect the liver, the hepatitis A and hepatitis C viruses actually have very little in common. The two are far apart genetically, are transmitted differently, and produce very different diseases. Hepatitis A spreads through the consumption of fecal particles from an infected person (in pollution-contaminated food or water, for example), but hepatitis C is generally transmitted only by direct contact with infected blood. Hepatitis A produces fever, nausea and abdominal pain that can last for weeks, but rarely leads to death; hepatitis C, by contrast, often spends decades quietly damaging the liver, until a victim’s only hope for survival is an organ transplant.

According to researchers at the University of Texas Medical Branch at Galveston (UTMB), though, these two otherwise unrelated liver viruses have one important thing in common: a trick for avoiding destruction by the immune system. Both dodge immune attacks by attacking the same protein — an essential link in a chain of molecular signals that triggers antiviral responses.

Article continues below and (thank you)

"With 30,000-plus proteins in the cell, it’s really remarkable that these two very different viruses have chosen to strike at the same one," said Stanley Lemon, director of UTMB’s Institute for Human Infections and Immunity and National Institutes of Health-funded Hepatitis C Research Center. Lemon is senior author of a paper on the research appearing online this week in the Proceedings of the National Academy of Sciences. "This identifies the protein — called MAVS, for mitochondrial antiviral signaling protein — as extremely important for the survival of any virus in the liver."

MAVS proteins project from tiny structures called mitochondria, which are found in large numbers in each liver cell. When specialized receptor molecules detect viruses in the cell, they dock with the MAVS proteins, thereby triggering a sequence of signals ending with the production of interferon beta — a potent inhibitor of virus replication. Recent research has shown that hepatitis C generates a protein called NS3/4A that chops up MAVS, interfering with immune signaling and possibly providing the cover the virus needs to survive so long in the liver. Now, Lemon and his group have demonstrated that hepatitis A does the same thing with a different protein, known as 3ABC.

"Hepatitis A never manages to establish a long-term infection like hepatitis C even though it also destroys MAVS," Lemon said. "This suggests that the degradation of this cell protein is not the main reason that hepatitis C becomes persistent. These results thus provide a new perspective on the chronicity of hepatitis C, which is a highly relevant virus clinically."

Hepatitis C has received far more research attention than hepatitis A in recent years, according to Lemon, largely because of hepatitis C’s chronic nature and the lack of a vaccine against it. But while better sanitation has driven a decline in hepatitis A cases in the United States, Lemon said, "It’s a significant risk for many people traveling overseas, because they fail to receive the vaccine." Hepatitis A has also been the cause of large food-borne outbreaks in the U.S. in recent years, including one in Pennsylvania that caused three deaths in otherwise healthy adults.

Other authors of the PNAS paper include lead author and former UTMB postdoctoral fellow Yan Yang, research associate Yuqiong Liang, graduate students Lin Qu and Zeming Chen, associate professor MinKyung Yi and assistant professor Kui Li. Funding for this research was provided by the National Institutes of Health, the American Liver Foundation, the James W. McLaughlin Endowment and the Effie and Wofford Cain Foundation.

Source: The University of Texas Medical Branch at Galveston